![Dieter Peters](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dieter Peters
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Dieter Peters
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Grünenthal GmbH
![]() Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.
15
| Subsidiary | Pharmaceuticals: Major | 15 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Dieter Peters via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
LABORATORIOS ANDROMACO S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Grunenthal Italia Srl
![]() Grunenthal Italia Srl Pharmaceuticals: MajorHealth Technology Grunenthal Italia Srl is an Italian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Milan, Italy. The CEO of the company is Gabriel Baertschi. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
RWTH Aachen University | College/University | Masters Business Admin Corporate Officer/Principal | |
Mariana Oncology, Inc.
![]() Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Founder | |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
The University of Southampton | College/University | Graduate Degree | |
The Medical Research Council
![]() The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
University of Hertfordshire | College/University | Doctorate Degree | |
The University of Manchester | College/University | Undergraduate Degree | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Grünenthal Ltd.
![]() Grünenthal Ltd. Medical DistributorsDistribution Services Part of Grünenthal Pharma GmbH & Co. KG, Grünenthal Ltd. is a British UK-based company founded in 2004. The company's mission is to improve the lives of patients, and they have a strong focus on innovation in the field of pain management. Grünenthal Ltd. has a healthy pipeline of products and is an ambitious and dynamic business. | Medical Distributors | Director/Board Member | |
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Consultant / Advisor | |
Grünenthal Pharma SA
![]() Grünenthal Pharma SA Pharmaceuticals: OtherHealth Technology Grünenthal Pharma SA engages in the development of pharmaceutical products. It specializes in anti-pain products. The company was founded on October 25, 1966 and is headquartered in Madrid, Spain. | Pharmaceuticals: Other | Director/Board Member | |
Ashridge Business School | College/University | Masters Business Admin | |
Applied Science University | College/University | Undergraduate Degree | |
Sandoz AG
![]() Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EALIXIR, INC. | Computer Communications | Chief Operating Officer | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
BASF SE | Electrical Products | Human Resources Officer | |
University of Münster | College/University | Doctorate Degree | |
Santi Therapeutics, Inc.
![]() Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Santi Therapeutics, Inc. provides pharmaceutical services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
Grünenthal Pharma GmbH & Co. KG
![]() Grünenthal Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Grünenthal Pharma GmbH & Co. KG engages in the development and manufacture of pharmaceutical products. It specializes in the treatment of pain and inflammation. The company is headquartered in Aachen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Private Equity Investor | |
Perm State Medical University | College/University | Doctorate Degree | |
Fairfield University | College/University | Graduate Degree | |
TECHNOTRANS SE | Industrial Machinery | Director of Finance/CFO | |
Sanvartis Group GmbH
![]() Sanvartis Group GmbH Medical/Nursing ServicesHealth Services Sanvartis Group GmbH operates telemedical centers and provides healthcare communication services. The company is based in Duisburg, Germany. The CEOs of the German company are Andreas Bleiziffer, Jan Hermann, Robin Schaede. | Medical/Nursing Services | Chief Executive Officer | |
Careforce Sanvartis Holding GmbH
![]() Careforce Sanvartis Holding GmbH Financial ConglomeratesFinance Careforce Sanvartis Holding GmbH is an investment holding private company based in Cologne, Germany. and has subsidiaries in Germany. The CEOs are Manuel Ebner, Robin Schaede. The German company was founded in 2018. | Financial Conglomerates | Chief Executive Officer | |
Grünenthal USA, Inc.
![]() Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Grünenthal USA, Inc. is a pharmaceutical company based in Morristown, NJ. The private company manufactures and distributes pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Daiichi Sankyo Europe GmbH
![]() Daiichi Sankyo Europe GmbH Pharmaceuticals: MajorHealth Technology Daiichi Sankyo Europe GmbH manufactures pharmaceutical products. The company was founded on January 22, 1910 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Universidad Central del Este | College/University | Doctorate Degree | |
VALNEVA | Biotechnology | Chief Tech/Sci/R&D Officer | |
BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
UCB Pharma, Inc.
![]() UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Warwick Business School | College/University | Doctorate Degree | |
OXFORD BIOMEDICA PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Université de Neuchâtel | College/University | Graduate Degree | |
AstraZeneca Thailand Ltd.
![]() AstraZeneca Thailand Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Thailand Ltd. operates as a science-led biopharmaceutical company. The company is based in Bangkok, Thailand. | Pharmaceuticals: Major | President | |
AstraZeneca GmbH
![]() AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Pharmaceuticals: Major | President | |
AstraZeneca KK
![]() AstraZeneca KK Pharmaceuticals: MajorHealth Technology AstraZeneca KK develops, manufactures and sells prescription drugs. It also conducts medical research. The company was founded on April 11, 1975 and is headquartered in Osaka, Japan. | Pharmaceuticals: Major | President | |
DKSH HOLDING AG | Medical Distributors | Director/Board Member | |
MedXCell SA
![]() MedXCell SA BiotechnologyHealth Technology MedXCell SA is a European cell therapy venture builder that focuses on identifying scientific breakthroughs and transforming them into clinical assets. The private company is based in Montreux, Switzerland. The Swiss company has a strong industrial mindset and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development, and funding capabilities. MedXCell scouts for promising ideas within its European academic network of partners, selects the most commercially-viable ideas, and co-develops them with academic institutions until the proof-of-principle stage. The company creates pipeline companies based on those ideas that can be funded independently and monetizes those that can be sold or out-licensed as early-stage assets. MedXCell was founded in 2016 by Laurent Zbinden, who has been the CEO since then. | Biotechnology | Director/Board Member | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
University of Copenhagen | College/University | Doctorate Degree | |
RWE AG | Electric Utilities | Corporate Officer/Principal | |
Novadip Biosciences SA
![]() Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Chairman |
Statistieken
Internationaal
Verenigde Staten | 14 |
Duitsland | 12 |
Verenigd Koninkrijk | 9 |
Zwitserland | 5 |
Denemarken | 3 |
Sectoraal
Health Technology | 25 |
Consumer Services | 14 |
Commercial Services | 4 |
Health Services | 3 |
Finance | 3 |
Operationeel
Corporate Officer/Principal | 30 |
Director/Board Member | 26 |
Chief Executive Officer | 17 |
Chief Tech/Sci/R&D Officer | 9 |
Doctorate Degree | 8 |
Sterkste connecties
- Beurs
- Insiders
- Dieter Peters
- Bedrijfsconnecties